Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes
Cesare Berra, Veronica Resi, Marco Mirani, L. Folini, Antonio Rossi, Sebastiano Bruno Solerte, Paolo Fiorina
Topics & Concepts
DulaglutideMedicineDiscontinuationInternal medicineType 2 diabetesDiabetes mellitusAdverse effectGlucagon-like peptide 1 receptorPopulationRetrospective cohort studyTolerabilityExenatideEndocrinologyAgonistEnvironmental healthReceptorDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research